32 filings
8-K
AMLX
Amylyx Pharmaceuticals Inc
21 Jun 24
Entry into a Material Definitive Agreement
5:07pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
6 Jun 24
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
9 May 24
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
7:05am
8-K
AMLX
Amylyx Pharmaceuticals Inc
10 Apr 24
Other Events
9:19am
8-K
AMLX
Amylyx Pharmaceuticals Inc
4 Apr 24
Cost Associated with Exit or Disposal Activities
7:10am
8-K
hx9gds u9
14 Mar 24
Departure of Directors or Certain Officers
9:18am
8-K
l399ol9 mob
8 Mar 24
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX
7:10am
8-K
vque9qv rjt
22 Feb 24
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7:08am
8-K
39u4glpu3ql7k399 wa6
7 Dec 23
Regulation FD Disclosure
7:00am
8-K
yxqgy07f7h0b6ba
9 Nov 23
Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
6:58am
8-K
00scld
13 Oct 23
Other Events
5:20pm
8-K
ido1k
10 Aug 23
Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:00pm
8-K
49f1nt 8m
26 Jul 23
Other Events
4:36pm
8-K
tt4o8
23 Jun 23
Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation
5:16pm
8-K
uc8ww
9 Jun 23
Submission of Matters to a Vote of Security Holders
8:14am
8-K
2ohxc
11 May 23
Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results
4:00pm
8-K
oq16bpm rjsjn5czyy2
21 Mar 23
Departure of Directors or Certain Officers
4:51pm
8-K
rjqmgvpsdm6s5ab
13 Mar 23
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
4:20pm
8-K
ca0h m0kai
14 Feb 23
Regulation FD Disclosure
6:30am
8-K
abwfz4
6 Dec 22
Entry into a Material Definitive Agreement
4:06pm